Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 E Garrigues, P Janvier, Y Kherabi, A Le Bot, A Hamon, H Gouze, L Doucet, ... Journal of Infection 81 (6), e4-e6, 2020 | 1236 | 2020 |
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 490 | 2017 |
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models JE Leggett, B Fantin, S Ebert, K Totsuka, B Vogelman, W Calame, ... Journal of infectious diseases 159 (2), 281-292, 1989 | 408 | 1989 |
Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection … JE Leggett, S Ebert, B Fantin, WA Craig Scand J Infect Dis 74 (Suppl 1), 179-184, 1991 | 191 | 1991 |
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams E Weiss, JR Zahar, P Lesprit, E Ruppe, M Leone, J Chastre, JC Lucet, ... Clinical Microbiology and Infection 21 (7), 649. e1-649. e10, 2015 | 179 | 2015 |
The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients J Stirnemann, M Vigan, D Hamroun, D Heraoui, L Rossi-Semerano, ... Orphanet journal of rare diseases 7, 1-13, 2012 | 159 | 2012 |
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria B Fantin, X Duval, L Massias, L Alavoine, F Chau, S Retout, A Andremont, ... Journal of Infectious Diseases 200 (3), 390-398, 2009 | 155 | 2009 |
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial BD Huttner, V De Lastours, M Wassenberg, N Maharshak, A Mauris, ... Clinical microbiology and infection 25 (7), 830-838, 2019 | 153 | 2019 |
In vivo antibiotic synergism: contribution of animal models B Fantin, C Carbon Antimicrobial Agents and Chemotherapy 36 (5), 907-912, 1992 | 152 | 1992 |
Prediction of the intestinal resistome by a three-dimensional structure-based method E Ruppé, A Ghozlane, J Tap, N Pons, AS Alvarez, N Maziers, T Cuesta, ... Nature microbiology 4 (1), 112-123, 2019 | 151 | 2019 |
Medical complications following splenectomy R Buzelé, L Barbier, A Sauvanet, B Fantin Journal of visceral surgery 153 (4), 277-286, 2016 | 146 | 2016 |
Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia A Lefort, X Panhard, O Clermont, PL Woerther, C Branger, F Mentré, ... Journal of clinical microbiology 49 (3), 777-783, 2011 | 143 | 2011 |
Evaluation of the management of postoperative aseptic meningitis V Zarrouk, I Vassor, F Bert, D Bouccara, M Kalamarides, N Bendersky, ... Clinical infectious diseases 44 (12), 1555-1559, 2007 | 136 | 2007 |
Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli B Fantin, S Ebert, J Leggett, B Vogelman, WA Craig Journal of antimicrobial chemotherapy 27 (6), 829-836, 1991 | 122 | 1991 |
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin OA Cornely, MA Miller, B Fantin, K Mullane, Y Kean, S Gorbach J Clin Oncol 31 (19), 2493-2499, 2013 | 119 | 2013 |
Comparative study of postoperative and spontaneous pyogenic spondylodiscitis V Dufour, A Feydy, L Rillardon, A Redondo, L Le Page, F Bert, ... Seminars in arthritis and rheumatism 34 (5), 766-771, 2005 | 119 | 2005 |
Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis V Zarrouk, A Feydy, F Salles, V Dufour, P Guigui, A Redondo, B Fantin Rheumatology 46 (2), 292-295, 2007 | 112 | 2007 |
Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus B Malbruny, A Canu, B Bozdogan, B Fantin, V Zarrouk, S Dutka-Malen, ... Antimicrobial agents and chemotherapy 46 (7), 2200-2207, 2002 | 111 | 2002 |
Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model B Fantin, J Leggett, S Ebert, WA Craig Antimicrobial agents and chemotherapy 35 (7), 1413-1422, 1991 | 110 | 1991 |
Guidelines on the management of infectious encephalitis in adults JP Stahl, P Azouvi, F Bruneel, T De Broucker, X Duval, B Fantin, N Girard, ... Med Mal Infect 47 (3), 179-94, 2017 | 98 | 2017 |